For cartilage restoration
Cartilage defects occur as the result of more than 900,000 injuries each year in the US alone.
​​
Our arthroscopically injectable hydrogel scaffold JointRep® is designed to enhance outcomes of the bone marrow stimulation procedure, offering an accessible, cost-effective first-line approach for cartilage repair.
​
JointRep® is not currently available in the United States.
​
For cartilage lubrication
Osteoarthritis remains a challenging condition to manage. The underlying causes are many, complex, and interrelated.
Gradual erosion of cartilage and degeneration of surrounding structures leads to growing symptoms of pain and impaired mobility. Treatment regimens are largely focused on controlling pain, with no real curative option currently available. Disease progression will often lead to total joint replacement.
Since osteoarthritis is frequently associated with a thinning of the synovial fluid, hyaluronic acid (HA) injections are used to restore its viscoelastic properties.
One factor limiting the effectiveness of HA is its rapid natural turnover in synovial fluid. In a healthy joint, HA is constantly produced and degraded by a specific enzyme called hyaluronidase. This enzyme causes injected HA to be rapidly eliminated. Some commercial formulations resort to the chemical cross-linking of HA to enhance its residence time.
Oligo Medic is conceiving of a new approach to viscosupplementation, aiming for effective and long-lasting lubrication of joints under abrasive stress through purposefully engineered biomaterials.
Oligo Medic is currently completing pre-clinical validation of its LOMU® formulation.
​